50 Companies Considered IPOs: Only 3 Went Public

The Norwegian IPO market remains stubbornly cool. Despite interest from over 50 companies exploring a public listing through the IPOready platform, only three have successfully completed the process: Appear, Moreld, and Oncoinvent, according to a recent report in Finansavisen. This suggests a challenging environment for companies seeking to tap public markets, even as global equity markets demonstrate signs of recovery.

A Narrow Window for New Listings

The IPOready platform, designed to prepare companies for a potential listing, saw significant engagement, indicating a desire among Norwegian businesses to access capital through equity markets. Yet, the conversion rate – the number of companies actually going public – is strikingly low. The three successful IPOs represent a 6% success rate, a figure that underscores the heightened scrutiny and risk aversion currently prevalent among investors.

Appear, a software company, Moreld, a technology and industrial investment company, and Oncoinvent, a biotechnology firm focused on cancer immunotherapy, managed to navigate the complex process of an initial public offering. Details regarding the size and valuation of each offering were not immediately available in the Finansavisen report, but their completion signals a degree of investor confidence in these specific businesses.

Broader Market Conditions and Investor Sentiment

The subdued IPO activity in Norway mirrors a broader trend observed in global markets. While 2025 saw a number of IPOs, including Verisure, Asmodee, and Posti Group (as detailed in Nordnet’s list of 2025 IPOs), the overall volume remains below historical averages. Several factors contribute to this cautious approach. Persistent macroeconomic uncertainty, including inflation concerns and geopolitical risks, have made investors more selective. Rising interest rates also increase the cost of capital, making IPOs less attractive for companies and potentially reducing investor demand.

The performance of companies that did go public in 2025 is also mixed, as highlighted by Nordnet’s data. Several listings, such as Verisure and Asmodee, have experienced significant declines in share price since their IPO, demonstrating the inherent risks associated with investing in newly listed companies. This negative performance likely contributes to the current hesitancy among both companies considering an IPO and investors evaluating potential opportunities.

The IPO Process: A Closer Look

An Initial Public Offering (IPO) is the process by which a private company offers shares to the public for the first time. It’s a complex undertaking, typically involving investment banks that act as underwriters, assessing the company’s valuation, preparing a prospectus (a detailed document outlining the company’s business, financial performance, and risks), and marketing the shares to potential investors. The process is heavily regulated, requiring approval from financial authorities to ensure transparency and investor protection.

Companies choose to go public for a variety of reasons, primarily to raise capital for growth, expansion, or debt repayment. A public listing also provides liquidity for existing shareholders and can enhance the company’s profile and brand recognition. However, it also comes with increased scrutiny, reporting requirements, and the pressure to deliver short-term results to satisfy public shareholders.

Sector-Specific Challenges and Opportunities

The limited information available doesn’t indicate which sectors were most represented among the 50 companies considering an IPO. However, the successful listings of Appear (software), Moreld (technology/industrial), and Oncoinvent (biotechnology) suggest that these sectors may be relatively more attractive to investors. The biotechnology sector, in particular, often attracts significant investor interest due to its potential for high growth, but it also carries substantial risk due to the lengthy and expensive drug development process.

The broader Norwegian economy is heavily reliant on the energy sector, particularly oil and gas. While these companies often have strong financial performance, they may face increasing pressure from environmental concerns and the transition to renewable energy sources. This could produce it more challenging for energy companies to attract investors in an IPO, particularly those with a high carbon footprint.

What’s Next for the Norwegian IPO Market?

The near-term outlook for the Norwegian IPO market remains uncertain. Several factors will influence the pace of activity in the coming months. A stabilization of macroeconomic conditions, a decline in interest rates, and a more positive investor sentiment could encourage more companies to pursue a public listing. However, continued volatility in global markets and concerns about a potential recession could further dampen investor appetite.

Companies considering an IPO will likely demand to demonstrate a strong track record of growth, profitability, and a clear path to future success. They will also need to be prepared to offer a compelling valuation and address any potential risks or concerns raised by investors. The success of future IPOs will depend on the ability of companies to navigate these challenges and convince investors that they represent a worthwhile investment opportunity.

Looking ahead, monitoring the performance of the three companies that recently went public – Appear, Moreld, and Oncoinvent – will be crucial. Their success or failure will likely influence the decisions of other companies considering an IPO and provide valuable insights into the current state of the Norwegian equity market. Further analysis of the reasons why the other 47 companies ultimately decided against pursuing a listing could also shed light on the challenges facing the Norwegian IPO market. Google Finance provides a useful resource for tracking market trends and individual stock performance.